DOSING SCHEDULE
IXCHIQ® is given as a single reconstituted single intramuscular dose in the deltoid muscle.1
IXCHIQ dosing schedule1*
*IXCHIQ® should be given no later than 30 days prior to travel, by a healthcare professional with experience of conducting benefit-risk assessments for live vaccines.1
**To be administered as a 0.5 ml intramuscular injection after reconstitution.1
CO-ADMINISTRATION WITH OTHER VACCINES
IXCHIQ® is not recommended to be co-administered with other vaccines because there are no data on safety and immunogenicity following concomitant administration of IXCHIQ® with other vaccines.1
Administration of immune globulins or plasma transfusions three months before or up to one month after IXCHIQ® administration may interfere with the expected immune response.1
LEARN MORE ABOUT IXCHIQ®
Delve deeper into the product features, clinical findings and dosing recommendations.
IXCHIQ®▼powder and solvent for solution for injection
OVERVIEW
Get a useful overview of IXCHIQ®, including key facts about the vaccine.
IXCHIQ®▼powder and solvent for solution for injection
CLINICAL DATA
Explore the latest clinical data on the efficacy and safety profile of IXCHIQ®.
References
- IXCHIQ®. Summary of Product Characteristics. March 2026. Available at: https://www.medicines.org.uk/emc/product/100652/smpc. Accessed: August 2026.
UK-IXC-2600005 August 2026